- Home
- SEM vs HRMY Comparison
SEM vs HRMY Comparison
Compare SEM & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEM
- HRMY
- Stock Information
- Founded
- SEM 1996
- HRMY 2017
- Country
- SEM United States
- HRMY United States
- Employees
- SEM N/A
- HRMY N/A
- Industry
- SEM Hospital/Nursing Management
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- SEM Health Care
- HRMY Health Care
- Exchange
- SEM Nasdaq
- HRMY Nasdaq
- Market Cap
- SEM 1.6B
- HRMY 1.5B
- IPO Year
- SEM 2009
- HRMY 2020
- Fundamental
- Price
- SEM $13.77
- HRMY $34.55
- Analyst Decision
- SEM Buy
- HRMY Strong Buy
- Analyst Count
- SEM 4
- HRMY 9
- Target Price
- SEM $16.33
- HRMY $50.44
- AVG Volume (30 Days)
- SEM 1.1M
- HRMY 902.8K
- Earning Date
- SEM 10-30-2025
- HRMY 11-04-2025
- Dividend Yield
- SEM 1.82%
- HRMY N/A
- EPS Growth
- SEM N/A
- HRMY 50.44
- EPS
- SEM 0.87
- HRMY 3.17
- Revenue
- SEM $5,368,760,000.00
- HRMY $825,944,000.00
- Revenue This Year
- SEM $5.45
- HRMY $20.68
- Revenue Next Year
- SEM $4.79
- HRMY $15.93
- P/E Ratio
- SEM $15.72
- HRMY $10.83
- Revenue Growth
- SEM 45.29
- HRMY 21.13
- 52 Week Low
- SEM $11.65
- HRMY $25.52
- 52 Week High
- SEM $39.74
- HRMY $40.93
- Technical
- Relative Strength Index (RSI)
- SEM 57.61
- HRMY 70.83
- Support Level
- SEM $12.61
- HRMY $32.77
- Resistance Level
- SEM $13.65
- HRMY $34.80
- Average True Range (ATR)
- SEM 0.42
- HRMY 1.36
- MACD
- SEM -0.03
- HRMY 0.23
- Stochastic Oscillator
- SEM 86.42
- HRMY 94.01
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.